Mirum Pharmaceuticals Inc (NASDAQ: MIRM) is 21.65% higher on its value in year-to-date trading and has touched a low of $23.14 and a high of $35.56 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MIRM stock was last observed hovering at around $34.43 in the last trading session, with the day’s gains setting it 1.48%.
Currently trading at $35.91, the stock is 17.52% and 31.54% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.01 million and changing 4.30% at the moment leaves the stock 27.08% off its SMA200. MIRM registered 36.80% gain for a year compared to 6-month loss of 20.99%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 36.54% gain in the last 1 month and extending the period to 3 months gives it a 36.75%, and is 5.03% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.82% over the week and 6.40% over the month.
Mirum Pharmaceuticals Inc (MIRM) has around 264 employees, a market worth around $1.69B and $224.00M in sales. Profit margin for the company is -69.67%. Distance from 52-week low is 55.19% and 0.98% from its 52-week high. The company has generated returns on investments over the last 12 months (-28.80%).
The EPS is expected to grow by 58.59% this year.
Mirum Pharmaceuticals Inc (MIRM) Top Institutional Holders
The shares outstanding are 46.72M, and float is at 37.92M with Short Float at 20.57%.
Mirum Pharmaceuticals Inc (MIRM) Insider Activity
The most recent transaction is an insider sale by Howe Jolanda,the company’sSVP, GLOBAL CONTROLLER. SEC filings show that Howe Jolanda sold 375 shares of the company’s common stock on Jul 02 ’24 at a price of $34.00 per share for a total of $12750.0. Following the sale, the insider now owns 2426.0 shares.
Mirum Pharmaceuticals Inc disclosed in a document filed with the SEC on Jun 24 ’24 that Vig Pamela (CHIEF SCIENTIFIC OFFICER) sold a total of 30,559 shares of the company’s common stock. The trade occurred on Jun 24 ’24 and was made at $34.00 per share for $1.04 million. Following the transaction, the insider now directly holds 27406.0 shares of the MIRM stock.
Still, SEC filings show that on Jun 05 ’24, Ramasastry Saira (Director) disposed off 5,000 shares at an average price of $25.68 for $0.13 million. The insider now directly holds 0 shares of Mirum Pharmaceuticals Inc (MIRM).
